Economic Growth and Jobs Minister Danny Pearson has announced a $75 million investment in five specialist venture capital funds that target climate-tech, health and life sciences, high-growth technology businesses and female founders.
Breakthrough Victoria will invest in the funds, including Virescent Ventures Fund II, Australia’s largest and most active dedicated climate technology investor, and SYNthesis BioVentures Fund I, founded in Victoria by oncology expert Professor Andrew Wilks, focussing on pioneering biomedical innovation.
“Breakthrough Victoria is committed to boosting investment in venture capital funds, aligning with Victoria’s Economic Growth Statement,” Breakthrough Victoria chief executive officer Rod Bristow said.
“This initiative will ensure innovative companies have the capital to grow and drive economic growth for our state.”
Scale Venture Fund I targets the critical gap in venture capital for female founders. Currently only three per cent of funding goes to startups led by all-women founders.
Galileo Ventures Fund II, a second-time fund manager, invests in emerging founders at the pre-seed and seed stages, with a focus on high-growth technology sectors.
Breakthrough Victoria will also make a cornerstone investment with a specialist North American health and life sciences fund manager as they launch their first Australian fund.
“We’re backing Victorian innovation to grow our economy and create more secure, high-skill jobs. When local ideas succeed, our whole state benefits,” Mr Pearson said.
“By helping startups and emerging businesses get the investment they need, we’re attracting private capital, boosting confidence, and building the industries and jobs of the future.”
An independent report by EY-Parthenon found Breakthrough Victoria’s portfolio is on track to generate $5.3 billion in economic impact for Victoria by 2035.
